Skip to main content

and
  1. Article

    Open Access

    BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia

    Targeted therapy has always been the focus in develo** therapeutic approaches in cancer, especially in the treatment of acute myeloid leukemia (AML). A new small molecular inhibitor, JQ1, targeting BRD4, whi...

    Yafeng Zhou, Jianbiao Zhou, **ao Lu, Tuan-Zea Tan, Wee-Joo Chng in BMC Cancer (2018)